H299 - MICROBIOLOGICAL LABORATORY TESTING

alyses, and delivering results that comply with USP standards and the specific requirements of VANEOHS. Pharmacy staff must undergo regular assessments, and sterile compounding areas must be sampled to ensure compliance with regulatory standards, including U.S. Pharmacopeia (USP) General Chapters <797> and <800>. These assessments are integral to a comprehensive quality assurance program that prioritizes patient safety, staff competency, and the maintenance of a controlled environment within sterile compounding spaces. Although trained pharmacy staff are responsible for conducting these tests, it is crucial that viable samples are incubated and analyzed by an independent third party to guarantee unbiased results. Consequently, it is essential to identify an appropriately accredited microbiological laboratory contractor that specializes in USP General Chapter <797> environmental and personnel sampling. See the following for accreditation requirements: United States Pharmacopeia (USP) https://www.usp.org; USP defines what must be tested, when it must be tested, how to perform testing, and the acceptance criteria for sterile compounding environments. American Association for Laboratory Accreditation (A2LA) https://a2la.org; A2LA accredits the vendor to the specific tests required by USP. ISO/IEC 17025 accreditation demonstrates the laboratory is competent to perform the testing methods correctly and consistently for valid results. The NAICS Code for this acquisition is 541380, size standard of $19.5 M. The Product Service Code (PSC) is H166. The contracting office is contemplating award of a Firm-Fixed-Price contract for this service. Contract length is anticipated to be Base plus 3 option years. Questions regarding this solicitation must be addressed to Thomas Bellamy at thomas.bellamy@va.gov and are due NLT Wednesday August 12th, 2026 by 3:00pm EST. Responses to this solicitation must be received via email NLT Wednesday August 19th 2026 by 3:00 pm EST.